Table 1.
Myelin Genes | |
PMP22 | MPZ |
-exonla | MAG |
-exonlb | MBP |
CLDN19 | PMP2 |
MAL | PLP1 |
CD9 | CNTF |
IL16 | PRX |
AATK | NDRG1 |
L1CAM | SOX10 |
UGT8 | EGR2 |
GPM6A | S100B |
GPR37L1 | DHH |
Injury Genes | |
GDNF | OLIG1 |
SHH | BDNF |
RUNX2 | HMGA2 |
FGF5 | CCL2 |
GFAP | UCN2 |
TMPRSS5 | |
CMT1A Genes | |
POU3F1 | NGFR |
CXCL14 | ID2 |
EDNRB | SOX4 |
SOX5 | CUEDC2 |
TTYH1 | BZW2 |
PLEKHA1 | |
Stable Genes | |
GPM6B | CNP |
CADM4 | PLLP |
PLEKHB1 | LGI4 |
NR4A2 | VGLL3 |
ERBB2 | ERBB3 |
GLDN |
Table 1. Custom Nanostring panel design.
The indicated list of genes were submitted to Nanostring for capture/detection probe design. Indicated categories are major myelin genes, genes induced in Schwann cells after nerve injury, genes shown to be induced rodent CMT1A models, and also Schwann cell genes that are relatively unchanged in nerve injury and/or neuropathy model profiles. Most genes were chosen based on evidence that their expression was Schwann cell-specific using published profiles of sorted cells and/or specific to human tibial nerve. Many peripheral nerve genes are also expressed in oligodendrocytes in the CNS. The complete list of genes and Refseq accession number used for probe design is in Supplemental Table 1.